-
1
-
-
0021969251
-
Efficacy of feverfew as prophylactic treatment of migraine
-
Johnson E.S., Kadam N.P., Hylands D.M., and Hylands P.J. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J (Clin Res Ed). 291 6495 (1985) 569-573
-
(1985)
Br Med J (Clin Res Ed).
, vol.291
, Issue.6495
, pp. 569-573
-
-
Johnson, E.S.1
Kadam, N.P.2
Hylands, D.M.3
Hylands, P.J.4
-
2
-
-
0023752998
-
Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
-
Murphy J.J., Heptinstall S., and Mitchell J.R. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 2 8604 (1988) 189-192
-
(1988)
Lancet
, vol.2
, Issue.8604
, pp. 189-192
-
-
Murphy, J.J.1
Heptinstall, S.2
Mitchell, J.R.3
-
3
-
-
0036731341
-
The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis-a double-blind, multicentre, randomized placebo-controlled dose-response study
-
Pfaffenrath V., Diener H.C., Fischer M., Friede M., and Henneicke-von Zepelin H.-H. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis-a double-blind, multicentre, randomized placebo-controlled dose-response study. Cephalalgia 22 7 (2002) 523-532
-
(2002)
Cephalalgia
, vol.22
, Issue.7
, pp. 523-532
-
-
Pfaffenrath, V.1
Diener, H.C.2
Fischer, M.3
Friede, M.4
Henneicke-von Zepelin, H.-H.5
-
4
-
-
27444444838
-
2-extract (MIG-99) in migraine prevention a randomized, double-blind, multicentre, placebo-controlled study
-
2-extract (MIG-99) in migraine prevention a randomized, double-blind, multicentre, placebo-controlled study. Cephalalgia 25 11 (2005) 1031-1041
-
(2005)
Cephalalgia
, vol.25
, Issue.11
, pp. 1031-1041
-
-
Diener, H.1
Pfaffenrath, V.2
Schnitker, J.3
Friede, M.4
Henneicke-von Zepelin, H.-H.5
-
5
-
-
0002279418
-
Feverfew
-
Hobbs C. Feverfew. Herbal Gram 20 (1989) 26-36
-
(1989)
Herbal Gram
, vol.20
, pp. 26-36
-
-
Hobbs, C.1
-
7
-
-
0034485867
-
The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review
-
[Review] [34 refs]
-
Ernst E., and Pittler M.H. The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review. Public Health Nutr 3 4A (2000) 509-514 [Review] [34 refs]
-
(2000)
Public Health Nutr
, vol.3
, Issue.4 A
, pp. 509-514
-
-
Ernst, E.1
Pittler, M.H.2
-
8
-
-
0027030454
-
Progress in the medicinal chemistry of the herb feverfew
-
Groenewegen W.A., Knight D.W., and Heptinstall S. Progress in the medicinal chemistry of the herb feverfew. Prog Med Chem 29 (1992) 217-238
-
(1992)
Prog Med Chem
, vol.29
, pp. 217-238
-
-
Groenewegen, W.A.1
Knight, D.W.2
Heptinstall, S.3
-
9
-
-
0029311312
-
Feverfew: chemistry and biological activity
-
Knight D.W. Feverfew: chemistry and biological activity. Nat Prod Rep 12 3 (1995) 271-276
-
(1995)
Nat Prod Rep
, vol.12
, Issue.3
, pp. 271-276
-
-
Knight, D.W.1
-
10
-
-
0023221336
-
Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups
-
Heptinstall S., Groenewegen W.A., Spangenberg P., and Loesche W. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups. J Pharm Pharmacol 39 6 (1987) 459-465
-
(1987)
J Pharm Pharmacol
, vol.39
, Issue.6
, pp. 459-465
-
-
Heptinstall, S.1
Groenewegen, W.A.2
Spangenberg, P.3
Loesche, W.4
-
11
-
-
0023613595
-
An extract of feverfew inhibits interactions of human platelets with collagen substrates
-
Losche W., Mazurov A.V., Heptinstall S., Groenewegen W.A., Repin V.S., and Till U. An extract of feverfew inhibits interactions of human platelets with collagen substrates. Thromb Res 48 5 (1987) 511-518
-
(1987)
Thromb Res
, vol.48
, Issue.5
, pp. 511-518
-
-
Losche, W.1
Mazurov, A.V.2
Heptinstall, S.3
Groenewegen, W.A.4
Repin, V.S.5
Till, U.6
-
12
-
-
0025096475
-
A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro
-
Groenewegen W.A., and Heptinstall S. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro. J Pharm Pharmacol 42 8 (1990) 553-557
-
(1990)
J Pharm Pharmacol
, vol.42
, Issue.8
, pp. 553-557
-
-
Groenewegen, W.A.1
Heptinstall, S.2
-
13
-
-
22644436784
-
Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine
-
Tassorelli C., Greco R., Morazzoni P., Riva A., Sandrini G., and Nappi G. Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine. Cephalalgia 25 8 (2005) 612-621
-
(2005)
Cephalalgia
, vol.25
, Issue.8
, pp. 612-621
-
-
Tassorelli, C.1
Greco, R.2
Morazzoni, P.3
Riva, A.4
Sandrini, G.5
Nappi, G.6
-
14
-
-
0036009156
-
Nuclear factor-kappaB as a molecular target for migraine therapy
-
Reuter U., Chiarugi A., Bolay H., and Moskowitz M.A. Nuclear factor-kappaB as a molecular target for migraine therapy. Ann Neurol 51 4 (2002) 507-516
-
(2002)
Ann Neurol
, vol.51
, Issue.4
, pp. 507-516
-
-
Reuter, U.1
Chiarugi, A.2
Bolay, H.3
Moskowitz, M.A.4
-
15
-
-
33749628447
-
-
NHMRC, Australian code of practice for the care and use of animals for scientific purposes. Canberra: Australian Government, 7th ed; 2004.
-
-
-
-
16
-
-
0018563564
-
Effect of acute maternal ethanol exposure upon foetal development in the rat
-
Samson H.H., Waterman D.L., and Woods S.C. Effect of acute maternal ethanol exposure upon foetal development in the rat. Phys Psych 7 (1979) 311-315
-
(1979)
Phys Psych
, vol.7
, pp. 311-315
-
-
Samson, H.H.1
Waterman, D.L.2
Woods, S.C.3
-
17
-
-
0014485109
-
A rapid method for detecting malformations in rat fetuses
-
Barrow M.V., and Taylor W.J. A rapid method for detecting malformations in rat fetuses. J Morphol 127 3 (1969) 291-305
-
(1969)
J Morphol
, vol.127
, Issue.3
, pp. 291-305
-
-
Barrow, M.V.1
Taylor, W.J.2
-
19
-
-
0001162208
-
Guidelines for developmental toxicity risk assessment
-
U.S. Environmental Protection Agency. Guidelines for developmental toxicity risk assessment. Federal Register 56 234 (1991) 63798-63826
-
(1991)
Federal Register
, vol.56
, Issue.234
, pp. 63798-63826
-
-
U.S. Environmental Protection Agency1
-
20
-
-
0006861363
-
Studies on mammalian fetuses in vitro during the period of organogenesis
-
Austin C.R. (Ed), Chapman and Hall, London
-
New D.A. Studies on mammalian fetuses in vitro during the period of organogenesis. In: Austin C.R. (Ed). The mammalian fetus in vitro (1973), Chapman and Hall, London 15-65
-
(1973)
The mammalian fetus in vitro
, pp. 15-65
-
-
New, D.A.1
-
21
-
-
0015153911
-
Cytotoxicity of sesquiterpene lactones
-
Lee K.H., Huang E.S., Piantadosi C., Pagano J.S., and Geissman T.A. Cytotoxicity of sesquiterpene lactones. Cancer Res 31 11 (1971) 1649-1654
-
(1971)
Cancer Res
, vol.31
, Issue.11
, pp. 1649-1654
-
-
Lee, K.H.1
Huang, E.S.2
Piantadosi, C.3
Pagano, J.S.4
Geissman, T.A.5
-
22
-
-
0019203640
-
Inhibition of DNA replication in HeLa S3 cells by macromomycin-I, an antitumor protein antibiotic
-
Woynarowski J.M., and Beerman T.A. Inhibition of DNA replication in HeLa S3 cells by macromomycin-I, an antitumor protein antibiotic. Mol Pharmacol 18 3 (1980) 491-496
-
(1980)
Mol Pharmacol
, vol.18
, Issue.3
, pp. 491-496
-
-
Woynarowski, J.M.1
Beerman, T.A.2
-
23
-
-
0019491333
-
Inhibition of DNA biosynthesis in HeLa cells by cytotoxic and antitumor sesquiterpene lactones
-
Woynarowski J.M., and Konopa J. Inhibition of DNA biosynthesis in HeLa cells by cytotoxic and antitumor sesquiterpene lactones. Mol Pharmacol 19 1 (1981) 97-102
-
(1981)
Mol Pharmacol
, vol.19
, Issue.1
, pp. 97-102
-
-
Woynarowski, J.M.1
Konopa, J.2
-
24
-
-
0024237235
-
Effects of an extract of feverfew (Tanacetum parthenium) on arachidonic acid metabolism in human blood platelets
-
Loesche W., Groenewegen W.A., Krause S., Spangenberg P., and Heptinstall S. Effects of an extract of feverfew (Tanacetum parthenium) on arachidonic acid metabolism in human blood platelets. Biomed Biochim Acta 47 10-11 (1988)
-
(1988)
Biomed Biochim Acta
, vol.47
, Issue.10-11
-
-
Loesche, W.1
Groenewegen, W.A.2
Krause, S.3
Spangenberg, P.4
Heptinstall, S.5
-
25
-
-
0016409683
-
Synthesis and cytotoxic activity of epoxides of helenalin related derivatives
-
Lee K.H., Kim S.H., and Furukawa H. Synthesis and cytotoxic activity of epoxides of helenalin related derivatives. Med Chem 18 (1975) 59-63
-
(1975)
Med Chem
, vol.18
, pp. 59-63
-
-
Lee, K.H.1
Kim, S.H.2
Furukawa, H.3
-
26
-
-
33749640914
-
Antitumor agent, 21, A proposed mechanism for inhibition of cancer growth by tenulin and helenalin and related cyclopentenones
-
Hall J.H., Lee K.H., and Mar E.C. Antitumor agent, 21, A proposed mechanism for inhibition of cancer growth by tenulin and helenalin and related cyclopentenones. Pharmacol Soc 67 (1977) 865-867
-
(1977)
Pharmacol Soc
, vol.67
, pp. 865-867
-
-
Hall, J.H.1
Lee, K.H.2
Mar, E.C.3
-
27
-
-
0026554566
-
Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products
-
Heptinstall S., Awang D.V., Dawson B.A., Kindack D., Knight D.W., and May J. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products. J Pharm Pharmacol 44 5 (1992) 391-395
-
(1992)
J Pharm Pharmacol
, vol.44
, Issue.5
, pp. 391-395
-
-
Heptinstall, S.1
Awang, D.V.2
Dawson, B.A.3
Kindack, D.4
Knight, D.W.5
May, J.6
-
28
-
-
0346689998
-
Transport of parthenolide across human intestinal cells (Caco-2)
-
Khan S.I., Abourashed E.A., Khan I.A., and Walker L.A. Transport of parthenolide across human intestinal cells (Caco-2). Planta Med 69 (2003) 1009-1012
-
(2003)
Planta Med
, vol.69
, pp. 1009-1012
-
-
Khan, S.I.1
Abourashed, E.A.2
Khan, I.A.3
Walker, L.A.4
|